- Home
- PHGE vs OMEX Comparison
PHGE vs OMEX Comparison
Compare PHGE & OMEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHGE
- OMEX
- Stock Information
- Founded
- PHGE 2015
- OMEX 1986
- Country
- PHGE Israel
- OMEX United States
- Employees
- PHGE N/A
- OMEX N/A
- Industry
- PHGE Biotechnology: Pharmaceutical Preparations
- OMEX Marine Transportation
- Sector
- PHGE Health Care
- OMEX Consumer Discretionary
- Exchange
- PHGE Nasdaq
- OMEX Nasdaq
- Market Cap
- PHGE 11.0M
- OMEX 11.0M
- IPO Year
- PHGE N/A
- OMEX N/A
- Fundamental
- Price
- PHGE $0.44
- OMEX $1.20
- Analyst Decision
- PHGE Strong Buy
- OMEX
- Analyst Count
- PHGE 1
- OMEX 0
- Target Price
- PHGE $15.00
- OMEX N/A
- AVG Volume (30 Days)
- PHGE 284.6K
- OMEX 2.7M
- Earning Date
- PHGE 08-13-2025
- OMEX 08-08-2025
- Dividend Yield
- PHGE N/A
- OMEX N/A
- EPS Growth
- PHGE N/A
- OMEX N/A
- EPS
- PHGE N/A
- OMEX 0.23
- Revenue
- PHGE N/A
- OMEX $700,613.00
- Revenue This Year
- PHGE N/A
- OMEX N/A
- Revenue Next Year
- PHGE N/A
- OMEX N/A
- P/E Ratio
- PHGE N/A
- OMEX $4.88
- Revenue Growth
- PHGE N/A
- OMEX N/A
- 52 Week Low
- PHGE $0.34
- OMEX $0.27
- 52 Week High
- PHGE $3.86
- OMEX $5.46
- Technical
- Relative Strength Index (RSI)
- PHGE 43.34
- OMEX 51.45
- Support Level
- PHGE $0.43
- OMEX $1.08
- Resistance Level
- PHGE $0.48
- OMEX $1.43
- Average True Range (ATR)
- PHGE 0.05
- OMEX 0.16
- MACD
- PHGE 0.00
- OMEX -0.02
- Stochastic Oscillator
- PHGE 58.82
- OMEX 24.51
About PHGE BiomX Inc. COmmon Stock
BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).
About OMEX Odyssey Marine Exploration Inc.
Odyssey Marine Exploration Inc is a deep-ocean exploration company. The company provides specialized mineral exploration, project development, and marine services to clients. It is engaged in the discovery, validation, and development of subsea mineral deposits in a socially and environmentally responsible manner. The company works with governments to identify mineral resources in Exclusive Economic Zones, focusing on phosphorite (fertilizer) and polymetallic nodule (battery metals) projects. Its projects include ExO Phosphate project, CIC, Ocean Minerals, and LIHIR Gold project.